FDA Approved: METOPIRONE — Supplemental Application (HRA Pharma Rare Diseases)

View source ↗

Summary

FDA approved a supplemental application for METOPIRONE (metyrapone) submitted by HRA Pharma Rare Diseases, resulting in an updated indication labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome

Drugs mentioned

• Metopirone (metyrapone)

Snippet

SUPPL AP for METOPIRONE (METYRAPONE)